Table 3.

Type-specific HPV infection distribution by country at enrollment

	Brazil (N = 382)	Mexico (N = 362)	United States (N = 416)	Total (N = 1,160)
	n (%)	n (%)	n (%)	n (%)
Oncogenic types
16	27 (7.1)	20 (5.5)	28 (6.7)	75 (6.5)
18*	12 (3.1)	6 (1.7)	2 (0.5)	20 (1.7)
31	7 (4.2)	5 (1.4)	2 (0.5)	14 (1.2)
33	1 (0.6)	1 (0.3)	0 (0.0)	2 (0.2)
35	13 (3.4)	3 (0.8)	5 (1.2)	21 (1.8)
39	12 (3.1)	18 (5.0)	12 (2.9)	42 (3.6)
45	11 (2.9)	1 (0.3)	1 (0.2)	13 (1.1)
51	11 (2.9)	24 (6.6)	26 (6.3)	61 (5.3)
52	15 (3.9)	13 (3.6)	13 (3.1)	41 (3.5)
56	12 (3.1)	7 (1.9)	5 (1.2)	24 (2.1)
58	15 (3.9)	7 (1.9)	5 (1.2)	27 (2.3)
59	19 (5.0)	26 (7.2)	17 (4.1)	61 (5.3)
66	25 (6.5)	15 (4.1)	18 (4.3)	58 (5.0)
Nononcogenic types
6*	36 (9.4)	15 (4.1)	26 (6.3)	77 (6.6)
11*	11 (2.9)	6 (1.7)	0 (0.0)	17 (1.5)
26	3 (0.8)	0 (0.0)	1 (0.2)	4 (0.3)
40	6 (1.6)	4 (1.1)	5 (1.2)	15 (1.3)
42	7 (1.8)	3 (0.8)	4 (1.0)	14 (1.2)
44	10 (2.6)	7 (1.9)	6 (1.4)	23 (2.0)
53	29 (7.6)	8 (2.2)	19 (4.6)	56 (4.8)
54	12 (3.1)	11 (3.0)	8 (1.9)	31 (2.7)
61	35 (9.2)	16 (4.4)	8 (1.9)	59 (5.1)
62	41 (10.7)	20 (5.5)	24 (5.8)	85 (7.3)
64	0 (0.0)	1 (0.3)	0 (0.0)	1 (0.1)
67	2 (0.5)	1 (0.3)	1 (0.2)	4 (0.3)
68	10 (2.6)	12 (3.3)	9 (2.2)	31 (2.7)
69	2 (0.5)	0 (0.0)	1 (0.2)	3 (0.3)
70	14 (3.7)	7 (1.9)	5 (1.2)	26 (2.2)
71	4 (1.1)	9 (2.5)	0 (0.0)	13 (1.1)
72	8 (2.1)	3 (0.8)	3 (0.7)	14 (1.2)
73	13 (3.4)	2 (0.6)	0 (0.0)	15 (1.3)
81	23 (6.0)	13 (3.6)	6 (1.4)	42 (3.6)
82	0 (0.0)	2 (0.6)	6 (1.4)	8 (0.7)
83	11 (2.9)	12 (3.3)	11 (2.6)	34 (2.9)
84	35 (9.2)	24 (6.6)	30 (7.2)	89 (7.7)
CP6108	31 (8.1)	16 (4.4)	19 (4.6)	66 (5.7)
IS39	3 (0.8)	0 (0.0)	2 (0.5)	5 (0.4)

NOTE: Due to infection with multiple HPV types, the percentages of infection exceed 100%.

^*HPV type distribution significantly different by region (P < 0.010).